Anti Cancer Drugs

• Application
• Other, Intramuscular Injection

• Dosage Form
• Lyophilized Powder for Injection

• Enzymatic Activity
• Somatostatin analog activity, inhibits secretion of various hormones

• Enzyme Types
• Other, Non-Enzymatic (Peptide Analog of Somatostatin)

• Feature
• Other, Long-acting formulation, sustained-release, single-dose vial

• Fermentation Smell
• Other, Odorless (Non-fermented)

• Indication
• Treatment of acromegaly, neuroendocrine tumors, carcinoid syndrome and vasoactive intestinal peptide-secreting tumors (VIPomas)

• Ingredients
• Other , Each vial contains Octreotide Acetate 30 mg, Excipients Q.S.

• Ph Level
• Approximately 4.0 to 5.0 after reconstitution

• Physical Color/Texture
• Other , White to off-white lyophilized cake or powder

• Salt Composition
• Octreotide Acetate

• Shelf Life
• 24 months from production date

• Storage Instructions
• Store below 25C, protect from light, do not freeze

• Temperature Needed For Fermentation
• Not Applicable (Synthetic production)

• Application
• Other, Subcutaneous or intravenous injection after reconstitution

• Dosage Form
• Lyophilized Powder for Injection

• Enzyme Types
• Other, Peptide analog of somatostatin

• Feature
• Other, High purity, sterile, ready for clinical use

• Fermentation Smell
• Other, Odorless

• Indication
• Acromegaly, neuroendocrine tumors, carcinoid syndrome, vasoactive intestinal peptide tumors

• Ingredients
• Other , Octreotide Acetate, Mannitol, Sodium Acetate, Sterile Water for Reconstitution

• Ph Level
• pH 4-5 (after reconstitution)

• Physical Color/Texture
• Other , White to off-white, lyophilized powder

• Salt Composition
• Octreotide Acetate 20 mg

• Shelf Life
• 24 months

• Storage Instructions
• Store between 2C - 8C. Protect from light. Do not freeze.

• Temperature Needed For Fermentation
• Not Applicable (synthetic, not fermentation derived)

• Application
• Other, Oral administration for patients with low platelet count

• Dosage Form
• Tablet

• Enzyme Types
• Other, Non-Enzymatic (Small Molecule)

• Feature
• Other, Highly effective platelet enhancer, convenient once-daily dosage

• Fermentation Smell
• Other, Odorless

• Indication
• Treatment of Thrombocytopenia in patients with chronic ITP or Hepatitis C

• Ingredients
• Other , Eltrombopag Olamine, Excipients

• Physical Color/Texture
• Other , Film-coated tablet, brown to tan colored

• Salt Composition
• Eltrombopag Olamine 50 mg

• Shelf Life
• 24 months

• Storage Instructions
• Store below 30C in a dry place, protected from light

• Application
• Other, Administered intramuscularly as prescribed by physician

• Dosage Form
• Injection

• Feature
• Other, Long-acting formulation for sustained release

• Fermentation Smell
• Other, Odorless

• Indication
• Treatment of prostate cancer, breast cancer, endometriosis, uterine fibroids, early puberty

• Ingredients
• Other , Leuproide Acetate, sterile water for injection, excipients

• Ph Level
• Neutral (approx. pH 7.0)

• Physical Color/Texture
• Other , White to off-white lyophilized powder

• Salt Composition
• Leuproide Acetate 22.5 mg

• Shelf Life
• 24 months

• Storage Instructions
• Store below 25C; protect from light; do not freeze

• Application
• Other, Management of thrombocytopenia

• Dosage Form
• Tablet

• Feature
• Other, Film-coated for controlled release; oral administration

• Fermentation Smell
• Other, Odorless

• Indication
• Used for the treatment of thrombocytopenia in patients with chronic immune (idiopathic) thrombocytopenic purpura (ITP), and for patients with chronic hepatitis C-associated thrombocytopenia.

• Ingredients
• Other , Eltrombopag Olamine, excipients

• Physical Color/Texture
• Other , Light brown to beige tablet; smooth texture

• Salt Composition
• Eltrombopag Olamine

• Shelf Life
• 24 Months

• Storage Instructions
• Store below 30C in a dry place away from direct sunlight

• Application
• Other, Oral administration for cancer treatment as prescribed

• Dosage Form
• Capsule

• Enzyme Types
• Other, Not applicable (small molecule inhibitor)

• Feature
• Other, High-precision dosage, blister pack for stability, easy-to-swallow capsule

• Indication
• Used for the treatment of metastatic castration-resistant prostate cancer (mCRPC)

• Ingredients
• Other , Enzalutamide, excipients (microcrystalline cellulose, croscarmellose sodium, magnesium stearate, gelatin capsule shell)

• Physical Color/Texture
• Other , Off-white to yellow fine powder inside hard capsule

• Salt Composition
• Enzalutamide 80 mg

• Shelf Life
• 24 months from manufacturing date

• Storage Instructions
• Store below 30C, protect from light and moisture

• Application
• Other, Antineoplastic (Oncology/Hematology)

• Dosage Form
• Injection

• Feature
• Other, Ready-to-use, single-use vial

• Fermentation Smell
• Other, Odorless

• Indication
• Used in conditioning regimens prior to hematopoietic progenitor cell transplantation

• Ingredients
• Other , Busulfan, Excipient(s)

• Physical Color/Texture
• Other , Clear, colorless liquid

• Salt Composition
• Busulfan 60 mg/10 ml

• Shelf Life
• 2 years from the date of manufacture

• Storage Instructions
• Store below 30C. Protect from light. Do not freeze.

• Application
• Other, Pharmaceutical, Oncology

• Dosage Form
• Tablet

• Feature
• Other, High purity, consistent dosage

• Fermentation Smell
• Other, Odorless

• Indication
• Appetite stimulant, Breast cancer, Endometrial cancer

• Ingredients
• Other , Megestrol Acetate, Excipients

• Physical Color/Texture
• Other , White to off-white, film-coated tablets

• Salt Composition
• Megestrol Acetate

• Shelf Life
• 24 months

• Storage Instructions
• Store below 30C in a dry place, protected from light

• Application
• Other, Administered by healthcare professionals for hormonal therapy

• Dosage Form
• Injection

• Feature
• Other, Prolonged-release, effective for up to 3 months with single injection

• Fermentation Smell
• Other, Odorless

• Indication
• Palliative treatment of advanced prostate cancer, management of endometriosis, uterine fibroids, and precocious puberty

• Ingredients
• Other , Leuprorelin Acetate, excipients

• Physical Color/Texture
• Other , Lyophilized white to off-white powder

• Salt Composition
• Leuprorelin Acetate 11.25 mg

• Shelf Life
• 24 months

• Storage Instructions
• Store below 25C, protect from light and moisture

• Application
• Other, Oral administration for specific interstitial lung diseases

• Dosage Form
• Soft Gelatin Capsule

• Feature
• Other, High bioavailability and stable formulation

• Indication
• Used in the treatment of idiopathic pulmonary fibrosis (IPF), systemic sclerosis-associated interstitial lung disease (SSc-ILD), and other chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype

• Ingredients
• Other , Nintedanib and pharmaceutical excipients in a soft gelatin base

• Physical Color/Texture
• Other , Capsule; yellow and opaque with printed markings

• Salt Composition
• Nintedanib (150 mg)

• Shelf Life
• 24 months from the date of manufacture

• Storage Instructions
• Store below 30C, protect from moisture and light